Burning Rock Biotech

Burning Rock Biotech was compromised in a ransomware attack attributed to THEGENTLEMEN in April 2026. The organization, operating in the Healthcare sector in China, was added to the group's data leak site as part of an extortion campaign.

THEGENTLEMEN operates as a financially motivated ransomware-as-a-service (RaaS) operation, exfiltrating sensitive data and threatening public disclosure to pressure victims into paying ransom demands.

brbiotech.com zoominfo.com/c/burning-rock-biotech/426006520 Burning Rock Biotech Limited (NASDAQ: BNR), whose mission is to Guard Life via Science, focuses on the application of next generation sequencing (NGS) technology in the field of precision oncology. Its business consists of i) NGS-based therapy selection testing for late-stage cancer patients, with the leading market share in China and ii) NGS-based cancer early detection, which has moved beyond proof-of-concept R&D into the clinical validation stage